Under the microscope: Regeneus (ASX:RGS) - Leo Lee, Chief Executive Officer by Morgans Financial Limited published on 2020-08-18T03:16:01Z Morgans analyst Iain Wilkie sat down with Leo Lee, CEO of ASX listed regenerative medicine player Regeneus (ASX:RGS). The two speak on its recent partnership deal for osteoarthritis in Japan and what it means for the company. Genre Business